GBH - GENEVA — History
CCN 364054 | 3-year financial timeline | COVID resilience: 90/100
🛡️ Public data only — no PHI permitted on this instance.
$6M
Latest Revenue (FY2022)
+35.9%
Revenue CAGR (3yr)
24.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $3M | $5M | $6M | +11.2% | +35.9% |
| Operating Expenses | $4M | $4M | $4M | +8.3% | +8.2% |
| Operating Margin | -19.0% | 22.5% | 24.6% | +9.0% | +0.0% |
| Net Income | $-1M | $1M | $1M | +21.2% | +0.0% |
| Licensed Beds | 18 | 18 | 20 | +11.1% | +5.4% |
| Total Patient Days | 4,133 | 5,088 | 5,732 | +12.7% | +17.8% |
| Medicare Day % | 42% | 43% | 34% | -20.3% | -9.7% |
| Medicaid Day % | 0% | 1% | 0% | -86.6% | +1.5% |
COVID Impact & Recovery
Resilience Score: 90/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +84.8% ($3M → $6M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+35.9%
This Hospital
+7.6%
State Avg
Latest Margin
24.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $7M | 46.4% |
| FY2024 (proj) | $8M | 68.2% |
| FY2025 (proj) | $10M | 90.0% |